• About
  • Subscribe
  • Advertise
  • Contact
Sunday, March 8, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Ray-Ban smart glasses bridge technology-fashion divide

by Myles Hume
September 13, 2021
in Business, Company updates & acquisitions, International, Local, News
Reading Time: 3 mins read
A A
Wearers can choose various lens styles, including sun, prescription, polarised, gradient, Transitions and clear.

Wearers can choose various lens styles, including sun, prescription, polarised, gradient, Transitions and clear.

Share on FacebookShare on Twitter

The first generation of Ray-Ban smart glasses from the highly anticipated EssilorLuxottica-Facebook collaboration have been unveiled and are now available in Australia with a $449 price tag.

The new eyewear – called Ray-Ban Stories – has been described as a new way for people to seamlessly capture, share and listen, in an announcement by Facebook founder Mr Mark Zuckerberg and EssilorLuxottica’s chief wearables officer Mr Rocco Basilico on 10 September.

Facebook is the latest tech company to enter the smart glasses race, following competitors like Google and the firm behind Snapchat, which have generated mixed results. The social media giant is now predicting that camera technology will become a standard eyewear feature within the next decade.

“We are incredibly proud to bring Ray-Ban Stories to life with our partners at Facebook,” Basilico said.

“This is a milestone product that proves consumers don’t have to choose between technology and fashion – they can live in the moment and stay connected while wearing their favourite style of Ray-Bans. Our unique approach, combining decades of superior craftsmanship, a dedicated spirit of innovation and a commitment to delivering only cutting-edge technology has resulted in a wearable that people will truly love wearing.”

 

Ray-Ban Stories Wayfarer – shiny black with blue light filter lenses.

EssilorLuxottica, Ray-Ban’s parent company, and Facebook have chosen the brand’s most recognisable style – Wayfarer and Wayfarer Large – to lead the product line up.

They are also available in various other styles such as the legendary, retro Round and the Meteor. Starting at AU$449, wearers can also choose a range of lens styles, including sun, prescription, polarised, gradient, Transitions and clear.

Facebook and EssilorLuxottica stated they have engineered smart technology to support all-day wear, including an optimised Snapdragon processor, without compromising style, comfort, and aesthetic.

Importantly, the companies have kept the eyewear lightweight – a common drawback of smart glass designs – with the Wayfarer styles just 5g more than a standard pair.

Ray-Ban Stories also include a dual integrated 5-megapixel camera to capture photo and video; discreet open-ear speakers, and a three-microphone audio array to deliver rich voice and sound transmission for calls and videos.

Additionally, Ray-Ban Stories has a companion app, Facebook View (iOS and Android), in what the companies say is an easy way to import, edit, and share content captured on the smart glasses with the ability to upload on any social app stored on a phone: Facebook, Instagram, WhatsApp, Messenger, Twitter, TikTok, Snapchat, and more.

“Ray-Ban Stories is designed to help people live in the moment and stay connected to the people they are with and the people they wish they were with,” Mr Andrew Bosworth, vice president of Facebook Reality Labs, said.

“EssilorLuxottica has been nothing short of stellar in this partnership and through their commitment to excellence we were able to deliver on both style and substance in a way that will redefine the expectations of smart glasses. We’re introducing an entirely new way for people to stay connected to the world around them and truly be present in life’s most important moments, and to look good while doing it.”

In his podcast following the launch, Mr Andrew Bosworth, who runs the Facebook’s hardware business, added that the ability to take pictures would be a standard feature for glasses within a decade.

“I think in 10 years it’ll be like, ‘Of course. Why don’t your glasses take pictures? That’s just weird,’” Bosworth said. “It really has that opportunity to turn the corner on that and move things forward.”

Ray-Ban Stories is available at Ray-Ban stores and Ray-Ban.com from September 10 in Australia. On September 13 they will also be available at select OPSM and Sunglass Hut stores (where not in lockdown).

More reading

EssilorLuxottica and Facebook are developing Ray-Ban smartglasses

Luxottica joins KeepSight; over half of optometry now registered

EssilorLuxottica completes GrandVision deal

Tags: EssilorLuxotticaFacebookRay-BanRay-Ban Storiessmart glasses

Related Posts

IOP is important but does not tell the full story of a patient's glaucoma. Image: Maria Sbytova/stock.adobe.com.

Solving the complex puzzle of glaucoma

by Dr Justin Sherwin
March 6, 2026

Early intervention is just one of many jigsaw pieces to ponder for eyecare professionals approaching glaucoma, says Australian Society of...

Researchers found that turtles can detect unexpected visual stimuli regardless of where those stimuli fall on the retina. Image: A. Martin UWphoto/stock.adobe.com

Research involving turtles challenges timeline of visual cortex evolution

by Staff Writer
March 6, 2026

Research into turtle brains is reshaping understanding of how visual systems evolved, with scientists reporting that position-invariant visual processing –...

Research has shown a link between sleep issues and dry eye. Image: WavebreakMediaMicro.

Be on lookout for dry eye, sleep disturbance link, optometrists urged

by Staff Writer
March 5, 2026

Optometrists are being encouraged to talk to dry eye patients about their sleep patterns after research established a link between...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited